Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease

Gut

Volumn 54, Issue 11, 2005, Pages 1579-1584

  Todhunter, C E ^b   Sutherland Craggs, A ^c   Bartram, S A ^b   Donaldson, P T ^c   Daly, A K ^b   Francis, R M ^b,c   Mansfield, J C ^b,c   Thompson, N P ^a,b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INTERLEUKIN 6; VITAMIN D RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEX RATIO; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; ADULT; AGED; BONE DENSITY; COLLAGEN TYPE I; CROHN DISEASE; FEMALE; GENOTYPE; HIP JOINT; HUMANS; INTERLEUKIN-6; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 27444443585     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.064212     Document Type: Article

References (45)

1. Klaus J, Armbrect G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-8.
2. Vestergaard P, Krogn K, Rejnmark L, et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000;46:176-81.
3. van Staa TP, Cooper C, Brusse LS, et al. Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-7.
4. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
5. Taylor BC, Schreiner PJ, Stone KL, et al. Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 2004;52:1479-86.
6. Jahnsen J, Falch JA, Aadland E, et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-19.
7. Siffiledeen JS, Fedorak RN, Siminoski K, et al. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 2004;10:220-8.
8. Schulte C, Dignass AU, Mann K, et al. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflamm Bowel Dis 1998;4:268-75.
9. Robinson RJ, al-Azzawi F, Iqbal SJ, et al. Osteoporosis and determinants of bone density in patients with Crohn's disease. Dig Dis Sci 1998;43:2500-6.
10. Pollak RD, Karmeli F, Eliakim R, et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998;93:1483-90.
11. Andreassen H, Hylander E, Rix M. Gender, age, and body weight are the major predictive factors for bone mineral density in Crohn's disease: a case-control cross-sectional study of 113 patients. Am J Gastroenterol 1999;94:824-8.
12. Silvennoinen JA, Lehtola JK, Niemela SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996;31:367-71.
13. Ralston SH. Genetic determinants of susceptibility to osteoporosis. Curr Opin Pharmacol 2003;3:286-90.
14. Spector TD, Keen RW, Arden NK, et al. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995;310:1357-60.
15. Hustmyer FG, Peacock M, Hui S, et al. Bone mineral density in relation to polymorphism at the vitamin D receptor. J Clin Invest 1994;94:2130-4.
16. Cooper GS, Umbach DM. Are vitamin D receptor polymorphisms associated with bone mineral density? J Bone Miner Res 1996;11:1841-9.
17. Dawson-Hughes B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995;80:3657-61.
18. Simmons JD, Mullighan C, Welsh KI, et al. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000;47:211-14.
19. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995;332:305-11.
20. Murray RE, McGuigan F, Grant SF, et al. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997;21:89-92.
21. Schulte CM, Dignass AU, Goebell H, et al. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterol 2000;119:909-20.
22. Willing MC, Pruchno CJ, Atkinson M, et al. Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen. Am J Hum Genet 1992;51:508-15.
23. Uitterlinden AG, Burger H, Huang Q, et al. Relation of alleles of the collagen type 1 (alpha) 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 1998;338:1016-21.
24. Grant SF, Reid DM, Blake G, et al. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 1996;14:203-5.
25. Mann V, Hobson E, Li B, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 2001;107:899-907.
26. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
27. Cuthbert AP, Fisher SA, Mirza MM, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002;122:867-74.
28. Bartram SA, Peaston RT, Rawlings DJ, et al. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Pharmacol Ther 2003;18:1121-7.
29. Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 1994;4:368-81.
30. Ferrari SL, Garnero P, Emond S, et al. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 2001;44:196-201.
31. Lorentzon M, Lorentzon R, Nordstrom P. Interleukin-6 gene polymorphism is related to bone mineral density during and after puberty in healthy white males: a cross-sectional and longitudinal study. J Bone Miner Res 2000;15:1944-9.
32. Schulte CMS, Goebell H, Roher HD, et al. Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease. Dig Dis Sci 2001;46:2521-8.
33. Manolagas SC. Role of cytokines in bone resorption. Bone 1995;17:63S-7.
34. Manolagas SC. The role of IL-6 type cytokines and their receptors in bone. Ann N Y Acad Sci 1998;840:194-204.
35. Scheldt-Nave C, Bismar H, Leidig-Bruckner G, et al. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001;86:2032-42.
36. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
37. Eastell R, Reid DM, Compston J, et al. A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 1998;244:271-92.
38. Mann V, Ralston SH. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003;32:711-17.
39. Martin K, Radlmayr M, Borchers R, et al. Candidate genes colocalized to linkage regions in inflammatory bowel disease. Digestion 2002;66:121-6.
40. Card T, West J, Hubbard R, et al. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004;53:251-5.
41. Vestergaard P, Mosekilde L. Fracture risk in patients with celiac disesae, Crohn's disease and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10.
42. Bernstein CN, Blanchard JF, Leslie W, et al. The incidence of fractures among patients with IBD: a population-based study. Ann Intern Med 2000;133:795-9.
43. Loftus EV, Crowson CS, Sandborn WJ, et al. Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmstead County, Minnesota. Gastroenterology 2002;123:468-75.
44. Adadchi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteriod induced osteoporosis. N Engl J Med 1997;337:382-7.
45. Sambrook PN, Kotowicz M, Nash P, et al. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner Res 2003;18:919-24.